Biomolecular Simulation for Drug Discovery

InterX is a biotechnology company that focuses on revolutionizing biomolecular computation to enhance the drug discovery process. Utilizing advanced principles from physics, mathematics, computer science, computational chemistry, and biology, InterX develops proprietary software tools that predict molecular interactions and the behaviors of complex biological systems. Their goal is to achieve a high level of accuracy in predicting ligand binding properties, specifically targeting an accuracy of 0.5 Kcal/Mol. This innovative approach allows for a more efficient and reliable prediction of real-world outcomes in biophysical processes, ultimately streamlining the drug discovery pipeline.

In addition to their computational capabilities, InterX emphasizes collaborative research and development, partnering with leading researchers and pharmaceutical companies worldwide. Their lab division applies computational and structural techniques to address critical biological challenges, particularly in developing new cancer therapies. By bridging the gap between academic research and the pharmaceutical industry, InterX aims to optimize the drug discovery process from target identification to lead optimization, leveraging their extensive expertise and proprietary tools to create novel therapeutic molecules.

United States

InterX is a biotech company focusing on the application of its proprietary computational tools & scientific platforms for the development of novel drug candidates. Led by Nobel-prize winning scientists, we make drug discovery faster, simpler and more accurate. 

We also partner with pharma companies, start-ups, academia and research organizations-applying our expertise, knowhow, and tools to jointly develop novel therapies. 

Contact us at: info@interx.dev

InterX

Company Details